Results 161 to 170 of about 61,679 (338)

The Role of Neonatal Nurses in the Prevention of Retinopathy of Prematurity. [PDF]

, 2016
The main risk factors for preterm babies developing retinopathy of prematurity (ROP) are poorly administered supplemental oxygen, infections, poor weight gain and transfusion of blood products, meaning ROP is sensitive to the quality of neonatal ...
Kalyan, G, Moxon, S
core  

Incidence of developmental disorders and special educational needs and disabilities in children in the UK

Developmental Medicine &Child Neurology, EarlyView.
The incidence of developmental disorders and special educational needs (SEN) provision were investigated, and associations with gestational age and ethnicity were explored, using the Born in Bradford cohort. Birth before full term was associated with increased odds of developmental disorder and/or SEN, which was even demonstrated in early term (37–38 ...
Katherine Pettinger, Sarah Blower, Elaine Boyle, Catherine Hewitt, Lorna Fraser   +4 more
wiley   +1 more source

Eficacia del bevacizumab en comparación con el ARGON láser, solo o en combinación, para el tratamiento de niños con retinopatía de la prematuridad [PDF]

, 2014
Introduction Retinopathy of prematurity is one of the main causes of avoidable blindness in newborns. ARGON laser ablation of the retina is the gold standard for the treatment of this pathology; however the use of vascular endothelial growth factor ...
Sánchez Almeida, Juan Martín
core  

Cardiorespiratory fitness and type 2 diabetes risk: A prospective cohort study with mediation analysis of biological aging in the UK Biobank

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Higher cardiorespiratory fitness is associated with reduced type 2 diabetes mellitus (T2D) risk, but the underlying mechanisms remain incompletely understood. We investigated whether biological aging mediates the association between maximal oxygen uptake (VO2max) and incident T2D risk.
Xiangliang Liu, Xinqiao Chen, Wang Yang, Guanran Ding, Yixin Zhao, Yuguang Li, Naifei Chen, Jiuwei Cui   +7 more
wiley   +1 more source

Baseline characteristics in the SYNCHRONIZE™‐2 randomized phase 3 trial of survodutide, a glucagon receptor/GLP‐1 receptor dual agonist, for obesity in people with type 2 diabetes

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Survodutide is an investigational glucagon receptor/glucagon‐like peptide‐1 receptor dual agonist that has shown promise for treating obesity and its complications in Phase 2 trials. Two double‐blind, randomized, global Phase 3 trials are designed to assess the efficacy and safety of survodutide for treatment of obesity—SYNCHRONIZE™‐1 in ...
Sean Wharton, Carel W. le Roux, Biykem Bozkurt, Elke Platz, Gabriele Bleckert, Samina Ajaz Hussain, Martina Brueckmann, Elena Startseva, Isabel M. Kloer, Lee M. Kaplan   +9 more
wiley   +1 more source

Enteral Arg-Gln Dipeptide Administration Increases Retinal Docosahexaenoic Acid and Neuroprotectin D1 in a Murine Model of Retinopathy of Prematurity [PDF]

, 2018
Lynn C. Shaw, Sergio Li Calzi, Nan Li, Leni Moldovan, Nilanjana Sengupta-Caballero, Judith Quigley, Mircea Ivan, Bokkyoo Jun, Nicolàs G. Bazàn, Michael E. Boulton, Julia V. Busik, Josef Neu, Maria B. Grant   +12 more
openalex   +1 more source

SGLT2 inhibitor or metformin as standard treatment in early‐stage type 2 diabetes? Baseline data in SMARTEST, a novel, decentralised, register‐based randomised trial on prevention of diabetic complications

Diabetes, Obesity and Metabolism, EarlyView.
Abstract Aims Metformin has hitherto not been proven superior to other type 2 diabetes (T2D) medications for the prevention of organ complications. The aim of this study is to report baseline data and blinded interim analyses in the register‐based randomised clinical trial (RRCT) SMARTEST, which compares metformin and the SGLT2 inhibitor dapagliflozin ...
Jan W. Eriksson, Giovanni Fanni, Martin H. Lundqvist, Stefan Jansson, Karin Rådholm, Sheyda Sofizadeh, Vagia Patsoukaki, Albert Nilsson, Daniel Lindholm, Olov Rolandsson, Anna Norhammar, Elisabet Granstam, Björn Eliasson, Louise Bennet, Johan Sundström   +14 more
wiley   +1 more source

Retinopathy of prematurity: it is time to take action. [PDF]

, 2017
Retinopathy of prematurity affects babies born preterm: before 37 weeks of gestation. Unless these babies are carefully managed, they can become visually impaired or blind.
Blencowe, Hannah, Gilbert, Clare
core   +1 more source

Cardiovascular biomarkers and preeclampsia: A narrative review

European Journal of Clinical Investigation, EarlyView.
Preeclampsia (PE) is a complex pregnancy disorder linked to cardiovascular disease (CVD) through shared risk factors and epidemiological associations. Cardiovascular biomarkers are valuable for predicting, diagnosing and assessing PE, as well as estimating future CVD risk. This review explores current cardiovascular biomarkers used in clinical practice
Johana Ullmo, Madalina Nicoleta Nan, Mónica Cruz‐Lemini, Carmen Garrido‐Gimenez, Judit Platero, Álvaro García‐Osuna, Pablo García‐Manau, Marcel Twickler, Elisa Llurba   +8 more
wiley   +1 more source

Omega-3 Long Chain Polyunsaturated Fatty Acid Supplementation for Prevention of Retinopathy of Prematurity in Pre-Term Low Birth Weight Infants: A Pilot Study. [PDF]

Health Sci Rep
ABSTRACT Background and Aims Retinopathy of prematurity (ROP) is a vasoproliferative disorder of the retina affecting preterm infants that potentially leads to blindness. Omega‐3 long‐chain polyunsaturated fatty acids (LCPUFA) have anti‐inflammatory and antiangiogenic effects, thereby reducing pathological neovascularization and preventing the ...
Afroz S, Hoque MM.
europepmc   +2 more sources